Skip to main content
IDWeek 2021 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Albert Liu, MD, MPH

Clinical Research Director
Bridge HIV, San Francisco Department of Public Health, CA, United States

Dr. Albert Liu is the Clinical Research Director of Bridge HIV within the San Francisco Department of Public Health and Associate Clinical Professor of Medicine at UCSF. His research focuses on the safety and effectiveness of PrEP agents, strategies to monitor and support PrEP adherence, and how best to implement PrEP in real-world settings. He is an investigator within the HIV Prevention Trials Network, Microbicide Trials Network, and the newly formed COVID Prevention Trials Network. He also serves as co-chair of the PrEP Committee of the San Francisco Getting to Zero Consortium and a member of the UCSF IRB. Dr. Liu is a board-certified internist and is currently an attending physician at San Francisco General Hospital.

Gilead Sciences (Individual(s) Involved: Self): Gilead has donated study drug for studies I have led., Grant/Research Support, Other Financial or Material Support, Research Grant or Support; IAS-USA (Individual(s) Involved: Self): Honorarium for manuscript writing, Other Financial or Material Support; Viiv Healthcare (Individual(s) Involved: Self): Grant/Research Support, Research Grant or Support

Presentation(s):